Clinical Trial Update: A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study [Phase 3]

View source ↗

Summary

Phase 3 long-term study of DE-117 ophthalmic solution, used alone and with timolol, in open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117 Ophthalmic Solution (DE-117)
• Timolol ophthalmic solution (timolol)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Status: COMPLETED